TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company Sponsored Studies With DRV
Clinical trial NCT01281813 · COMPLETED
Trial details
- NCT number
- NCT01281813
- Sponsor
- Janssen Sciences Ireland UC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-08
- Primary completion
- 2021-07-29
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.